The Spidermass project, developed by the PRISM laboratory – INSERM – University of Lille, supported by SATT Nord and incubated at Eurasanté, has been selected as part of Lille World Design Capital. This molecular analysis device provides real-time in vivo diagnosis, enabling guided cancer surgery.
The Lille-based agency Tweener is in charge of conducting a study among pathologists and surgeons, which will result in a set of specifications, a functional analysis, and a prioritization of functions before moving on to the design and prototyping of the device. The first results are expected at the end of November!
Discover the Lille European Capital of Design project: https://www.designiscapital.com/projet
Check out the Spidermass presentation video: